Fee Schedule & Billing Information

     

The University of Pittsburgh HRP established fees to help fund services provided by the Institutional Review Board (IRB), Institutional Biosafety Committee (IBC), and Radiation Safety, Human Use Sub Committee (HUSC).  Fees are charged for industry-sponsored research and research where Pitt is the Single IRB for external federally-funded sites conducting non-exempt human subjects research. 

Industry-Sponsored Research

Fees for industry-sponsored research cover the real cost associated with protocol review by the IRB, IBC, and HUSC. If subjects are never enrolled, the study terminates before milestones are met, expenditures exceed revenue, or a contract is never finalized, the investigator and department are responsible for all expenditures not covered by the sponsor, including IRB fees. Studies will not be reviewed until the fee is paid. 

A fee waiver can be requested under limited circumstances: 

  • The only support being provided by the industry-sponsor is the provision of a drug or device 

  • The industry support is less than $15,000 

The waiver is subject to approval by the Director of Administrative Support.      

Pitt IRB as the Single IRB (sIRB) for a Multi-Site Study     

The IRB is permitted to charge fees for studies where Pitt is serving as the IRB of Record for multiple research locations. A request for a budget must be submitted through the Reliance Request System prior to grant submission. The fees are based upon the number of relying sites, and number of years for the grant. A fee waiver can be requested under limited circumstances: 

  • There may be circumstances when sIRB fees were not budgeted into the initial grant application. With confirmation from the funding agency that the budget cannot be amended, an alteration or waiver of the fees can be requested. However, it may not be approved in which case the request for Pitt to serve as IRB of Record may be declined. 

           The waiver is subject to approval by the Reliance Team.

Billing Information

A fee sheet with the appropriate charges marked should be uploaded into PittPRO on the funding source page at the time of submission to the IRB. It is important that all applicable sections are completed to avoid delays in processing.

Fee Schedule — Industry-Sponsored Studies

New Studies Submitted After January 1, 2026
Review Type Full Board Expedited Exempt
Initial Application $3,000 $3,000 $1,000
Institutional Biosafety Committee (IBC) $2,500 one-time fee — effective July 1, 2026
Radiation Safety Human Use Subcommittee (HUSC) $2,000 one-time fee — effective July 1, 2026
Continuing Review $2,000 $1,500 N/A
Study-Wide Sponsor-Initiated Amendment $1,000 $1,000 $1,000
Study Close-Out $600 $600 $600
Ceded Study Reviewed by Commercial IRB $2,500 one-time fee — in addition to fees charged by the commercial IRB
New Studies Submitted Prior to January 1, 2026

Continuing Review: $1,500 Full Board / $1,500 Expedited / N/A Exempt

Fee Schedule — Pitt as IRB of Record

Grants Funded On/After June 1, 2021

Do not include Pitt/UPMC sites in the number of sites.

Onboarding Relying Sites $2,100 × number of relying sites
Continuing Review $250 × number of relying sites
Study-Wide Amendments $400 × number of relying sites
Grants Submitted On/Before June 1, 2021

Do not include Pitt/UPMC sites in the number of sites.

Fee Type Full Board Expedited
Initial Application / Modifications for the first year $1,750 $3,000
Onboarding Relying Sites $2,000 per site $1,000 per site
Continuing Review / Modifications for the next year $2,750 $2,250